Concord Drugs Ltd () Total Returns | Historical Performance, Beta, Dividend Yield & SENSEX Comparison

Concord Drugs VS Pharmaceuticals & Biotechnology

-1.02%

0.32%

13.58%

1.59%

-9.61%

-1.74%

YTD

-3.14%

-1.92%

124.41%

7.07%

147.34%

38.13%

219.56%

64.75%

10Y

83.02%

239.52%

Stock Absolute Returns
Absolute Returns

Price + Dividend

Total Returns (Price + Dividend)

Dividend Yield (0%)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

7.7%

6 Months

45.92%

1 Year

124.41%

2 Years

71.11%

3 Years

147.34%

4 Years

142.09%

5 Years

219.56%

Concord Drugs for the last several years.

Return Quartiles

What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.

Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers

Inconsistent Performance

Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods

Quartile

QTD

-5.41%

Quartile

Sep-Dec

23.66%

Quartile

Jun-Sep

61.27%

Quartile

120.4%

Quartile

2025

117.05%

Quartile

2024

-36.37%

Click on any of the quartiles for detailed breakdown

Return Quartiles - by Industry

Inconsistent Performance

Concord Drugs Ltd has not been a consistent performer in the last 1 year and longer periods

Quartile

QTD

-5.41%

Quartile

Sep-Dec

23.66%

Quartile

Jun-Sep

61.27%

Quartile

120.4%

Quartile

2025

117.05%

Quartile

2024

-36.37%

Click on any of the quartiles for detailed breakdown

Return Quartiles - by Market Cap

Not enough Stock Price history for Quartile Analysis

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available